Sied Kebir

2.9k total citations
76 papers, 1.2k citations indexed

About

Sied Kebir is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sied Kebir has authored 76 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Genetics, 30 papers in Pulmonary and Respiratory Medicine and 22 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sied Kebir's work include Glioma Diagnosis and Treatment (60 papers), Brain Metastases and Treatment (24 papers) and Radiomics and Machine Learning in Medical Imaging (14 papers). Sied Kebir is often cited by papers focused on Glioma Diagnosis and Treatment (60 papers), Brain Metastases and Treatment (24 papers) and Radiomics and Machine Learning in Medical Imaging (14 papers). Sied Kebir collaborates with scholars based in Germany, United States and United Kingdom. Sied Kebir's co-authors include Martin Glas, Ulrich Herrlinger, Björn Scheffler, Niklas Schäfer, Karl‐Josef Langen, Norbert Galldiks, Christina Schaub, Gabriele Stoffels, Ulrich Sure and Matthias Simon and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Sied Kebir

74 papers receiving 1.2k citations

Peers

Sied Kebir
MacLean P. Nasrallah United States
Kirsten Hopkins United Kingdom
Shannon Chang United States
Rajiv Magge United States
Akshal Patel United States
Jordonna Fulop United States
Frank Floeth Germany
MacLean P. Nasrallah United States
Sied Kebir
Citations per year, relative to Sied Kebir Sied Kebir (= 1×) peers MacLean P. Nasrallah

Countries citing papers authored by Sied Kebir

Since Specialization
Citations

This map shows the geographic impact of Sied Kebir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sied Kebir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sied Kebir more than expected).

Fields of papers citing papers by Sied Kebir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sied Kebir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sied Kebir. The network helps show where Sied Kebir may publish in the future.

Co-authorship network of co-authors of Sied Kebir

This figure shows the co-authorship network connecting the top 25 collaborators of Sied Kebir. A scholar is included among the top collaborators of Sied Kebir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sied Kebir. Sied Kebir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Layer, Julian Philipp, Dillon Corvino, Christina Schaub, et al.. (2023). 508MO Spatial remodeling of the immune tumor microenvironment after radiotherapy and CXCL12 inhibition in glioblastoma in the phase I/II GLORIA trial. Annals of Oncology. 34. S395–S395. 1 indexed citations
2.
Blau, Tobias, Ulrich Sure, Kathy Keyvani, et al.. (2023). Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma. Neuro-Oncology Advances. 5(1). 406–409.
3.
Lu, I‐Na, Laurèl Rauschenbach, Sarah Teuber‐Hanselmann, et al.. (2021). Tumor-associated hematopoietic stem and progenitor cells positively linked to glioblastoma progression. Nature Communications. 12(1). 3895–3895. 35 indexed citations
4.
Pöttgen, Christoph, Sied Kebir, Lazaros Lazaridis, et al.. (2021). Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial. Journal of Applied Clinical Medical Physics. 22(1). 242–250. 5 indexed citations
5.
Kebir, Sied, Elisabeth Livingstone, Andreas Junker, et al.. (2021). Case Report: Pseudomeningeosis and Demyelinating Metastasis-Like Lesions From Checkpoint Inhibitor Therapy in Malignant Melanoma. Frontiers in Oncology. 11. 637185–637185. 3 indexed citations
6.
Kebir, Sied, Matthias Weber, Lazaros Lazaridis, et al.. (2020). A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma. Cancers. 12(11). 3080–3080. 31 indexed citations
7.
Pierscianek, Daniela, Yahya Ahmadipour, Klaus Kaier, et al.. (2020). The SHORT Score for Preoperative Assessment of the Risk for Short-Term Survival in Glioblastoma. World Neurosurgery. 138. e370–e380. 7 indexed citations
8.
Shi, Wenyin, Deborah T. Blumenthal, Nancy Ann Oberheim Bush, et al.. (2020). Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice. Journal of Neuro-Oncology. 148(3). 489–500. 46 indexed citations
9.
Rauschenbach, Laurèl, Sied Kebir, Alexander Radbruch, et al.. (2020). Challenging Implications of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids Syndrome with an Atypical Presentation: Report of Two Cases. World Neurosurgery. 143. 507–512.e1. 4 indexed citations
10.
Kebir, Sied, Laurèl Rauschenbach, Alexander Radbruch, et al.. (2019). Regorafenib in patients with recurrent high-grade astrocytoma. Journal of Cancer Research and Clinical Oncology. 145(4). 1037–1042. 20 indexed citations
11.
Kebir, Sied, Manuel Weber, Lazaros Lazaridis, et al.. (2018). Hybrid 11C-MET PET/MRI Combined With “Machine Learning” in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016. Clinical Nuclear Medicine. 44(3). 214–220. 32 indexed citations
12.
Kebir, Sied, Laurèl Rauschenbach, Gerrit H. Gielen, et al.. (2018). Recurrent pseudoprogression in isocitrate dehydrogenase 1 mutant glioblastoma. Journal of Clinical Neuroscience. 53. 255–258. 2 indexed citations
13.
Bedarf, Janis R., et al.. (2017). Depression in blepharospasm: a question of facial feedback?. Neuropsychiatric Disease and Treatment. Volume 13. 1861–1865. 14 indexed citations
14.
Deuschl, Cornelius, Julian Kirchner, Thorsten D. Poeppel, et al.. (2017). 11C–MET PET/MRI for detection of recurrent glioma. European Journal of Nuclear Medicine and Molecular Imaging. 45(4). 593–601. 57 indexed citations
15.
Kebir, Sied, Zacharias Orfanos, Markus Linhart, et al.. (2016). Sarcomeric lesions and remodeling proximal to intercalated disks in overload-induced cardiac hypertrophy. Experimental Cell Research. 348(1). 95–105. 9 indexed citations
16.
Schaub, Christina, Julia Tichy, Niklas Schäfer, et al.. (2016). Prognostic factors in recurrent glioblastoma patients treated with bevacizumab. Journal of Neuro-Oncology. 129(1). 93–100. 22 indexed citations
17.
Schaub, Christina, Niklas Schäfer, Frederic Mack, et al.. (2016). The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastoma. Journal of Cancer Research and Clinical Oncology. 142(8). 1825–1829. 13 indexed citations
18.
Wolf, Michael, S. Lossdörfer, R. Meyer, et al.. (2013). In vivo differentiation of human periodontal ligament cells leads to formation of dental hard tissue. Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie. 74(6). 494–505. 12 indexed citations
19.
Wolf, Michael, S. Lossdörfer, Rainer Meyer, et al.. (2012). Effect of Intermittent PTH(1–34) on Human Periodontal Ligament Cells Transplanted into Immunocompromised Mice. Tissue Engineering Part A. 18(17-18). 1849–1856. 16 indexed citations
20.
Marier, Jean‐Francois, Sied Kebir, Sara Ferrón, et al.. (2006). Comparative bioavailability study of zidovudine administered as two different tablet formulations in healthy adult subjects. International Journal of Clinical Pharmacology and Therapeutics. 44(5). 240–246. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026